DeepTek.ai has unveiled Augmento X-Ray, a pioneering CADe Chest X-Ray AI solution at RSNA23. Augmento X-Ray promises to streamline chest X-ray interpretation, reducing radiologist workload and improving patient care. Powered by US FDA Cleared CXR AI, it covers the entire chest region, aiding in the detection of various abnormalities. With its proven success in India and Asia-Pacific, DeepTek.ai aims to make a significant impact in the US market, revolutionizing medical imaging and advancing diagnostic accuracy.
DeepTek.ai, a frontrunner in the realm of artificial intelligence (AI) solutions for medical imaging, has taken a monumental step forward with the unveiling of Augmento X-Ray, a groundbreaking CADe Chest X-Ray AI solution. This cutting-edge technology, powered by the US FDA Cleared CXR AI, was introduced at the prestigious Radiology Society of North America’s (RSNA) 109th Annual Meeting, marking a pivotal moment in medical innovation. Augmento X-Ray stands out as the world’s first commercially available AI solution of its kind, promising to revolutionize the interpretation of chest radiographs and elevate the standard of patient care.
The significance of chest radiography in clinical practice cannot be overstated, as it serves as the cornerstone for identifying various disease findings. With a staggering 3.5 billion annual X-rays performed worldwide, including 1.5 billion dedicated to chest examinations, the need for accurate and timely interpretation is paramount. However, the burden on radiologists is compounded by heavy workloads and a scarcity of experienced professionals, resulting in potential delays and missed detections.
In response to these challenges, Augmento X-Ray emerges as a beacon of hope, poised to alleviate the strain on radiologists and enhance the efficiency of chest X-ray reporting. By harnessing the power of AI, this innovative solution reduces radiologist workload by an impressive margin of 30-50%. By swiftly identifying suspicious findings on chest radiographs and distinguishing them from non-suspicious ones, Augmento X-Ray streamlines the interpretation process, thereby mitigating backlog issues and optimizing radiology workflow.
At the heart of Augmento X-Ray lies the US FDA Cleared AI solution CXR Analyzer, which enables comprehensive coverage of the entire chest region. From intricate lung and pleura analyses to cardiac assessments and the detection of foreign bodies and hardware within the chest, Augmento X-Ray offers a multifaceted approach to chest X-ray interpretation, ensuring thorough and accurate diagnoses.
Ajit Patil, Co-Founder of DeepTek, expressed his enthusiasm for this groundbreaking achievement, emphasizing the transformative impact of Augmento X-Ray on medical imaging. With US FDA clearance secured, Augmento X-Ray is poised to make waves in the US market, ushering in a new era of enhanced patient care and diagnostic precision.
DeepTek.ai has already established itself as a trailblazer in healthcare innovation, with a proven track record of success in India and the Asia-Pacific region. Their AI solutions have been instrumental in expanding access to quality care while simultaneously reducing costs. Currently deployed in over 500 hospitals and imaging centers, DeepTek’s products have positively impacted the lives of millions of individuals annually. Notably, in Singapore, Augmento Enterprise, DeepTek’s US FDA-approved platform, has been selected as the national radiology AI platform, driving improvements in productivity and care quality across public hospitals.
With a dedicated team of approximately 200 members and strategic partnerships with industry leaders such as TATA Capital, NTT DATA Japan, and Shimadzu Asia Pacific, DeepTek.ai is poised for global expansion. As the company sets its sights on penetrating the US market, leveraging its latest product launch and FDA approvals, it is poised to leave an indelible mark on the global healthcare landscape. Through innovation, collaboration, and a steadfast commitment to excellence, DeepTek.ai is poised to shape the future of medical imaging and redefine the standards of patient care worldwide.
DeepTek.ai’s Augmento X-Ray stands as a beacon of innovation in the field of medical imaging. With its ability to significantly reduce radiologist workload and improve diagnostic accuracy, this revolutionary solution has the potential to reshape the landscape of chest X-ray interpretation. As DeepTek.ai prepares to expand its reach into the US market, the future holds promising possibilities for Augmento X-Ray to enhance patient care and contribute to the advancement of medical science.
